IL‐4 inhibits VLA‐4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit
Kotaro Sasaki(Penn Center for AIDS Research), Walter J. Storkus(University of Pittsburgh Medical Center)
Cited by 23
Related Papers
Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy
|Journal of Immunotherapy|2002|299
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
|Journal for ImmunoTherapy of Cancer|2021|177
Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells
|Nature Communications|2020|147
Reconstitution of human adrenocortical specification and steroidogenesis using induced pluripotent stem cells
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2